A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy

Project: Research project

Project Details

Description

A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy
StatusFinished
Effective start/end date7/1/18 → 6/30/20

Funding

  • CATABASIS PHARMACEUTICALS